March 12, 2009 – Today, FDAnews and the Neocure Group revealed details today of the upcoming Medical Device Reimbursement Strategies Workshops, which will be held in Boston (April 30-May 1) and Minneapolis (August 24-25).

March 12, 2009 - CeloNova BioSciences Inc. said yesterday physicians performing a live stent implantation during the annual scientific meeting of the Sociedad Venezolana de Cardiologia Intervencionista (SOVECI), March 13-14, elected to use the CATANIA Coronary Stent System with NanoThin Polyzene-F to demonstrate the benefits of this innovative new stent technology.

March 11, 2009 - Siemens Healthcare will showcase advanced imaging applications like the new syngo iFlow and a new medical-grade large display, which provides a 56-inch active, full-color widescreen for procedures at SIR booth 400 in San Diego March 7 – 12, 2009.

March 10, 2009 - W. L. Gore & Associates today said the first clinical use of the GORE Flow Reversal System for neuroprotection during carotid artery stenting (CAS) was performed by Daniel McCormick, M.D. and Sheldon Goldberg, M.D., interventional cardiologists at Hahnemann University Hospital, Philadelphia.


March 11, 2009 - The St. Jude Medical Genesis neurostimulation system designed for managing chronic angina pectoris, or chronic angina, has received European CE approval.
The Genesis system helps to control angina pain by sending mild pulses of electricity from a device implanted in the torso via thin insulated wires called leads to nerves located along the spinal cord.

March 11, 2009 - With the joint development of the Ziehm NaviPort 3D interface, the medical technology manufacturing companies Ziehm Imaging and Stryker have succeeded in importing 2D and 3D C-arm image data into Stryker’s active infrared navigation systems.

March 11, 2009 - The Guidelines for the Interpretation and Reporting of Coronary Computed Tomographic Angiography report, published by the Society of Cardiovascular Computed Tomography (SCCT), will be printed in the March/April issue of the Journal of Cardiovascular Computed Tomography.

March 11, 2009 - Results from the PROTECT I trial evaluating the feasibility and effectiveness of the Abiomed Inc. Impella 2.5 circulatory assist device in high-risk percutaneous coronary intervention (PCI) procedures were published in the February issue of the Journal of the American College of Cardiology (JACC).

March 11, 2009 - The VAP Cholesterol Test from Atherotech Inc. is now available with apolipoprotein A (apoAI), reportedly increasing its clinical utility in the assessment of risk for heart disease, diabetes and other cardiovascular diseases, and making it the only single cholesterol test that routinely reports apoAI, apoB and the apoB/apoAI ratio.

March 11, 2009 – The use of common screening tests, such as the ankle brachial index (ABI), along with traditional risk scoring systems like the Framingham Risk Score, has the potential to prevent heart attacks in thousands of individuals who, based on their Framingham, are not originally thought to be at high risk, say researchers at the Society of Interventional Radiology's 34th Annual Scienti

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now